Eli Lilly's Valuation Path to $1 Trillion Linked to AI Boom

Eli Lilly's trajectory towards a $1 trillion valuation is seen as directly tied to the ongoing boom in artificial intelligence. Analysts suggest that AI advancements will play a significant role in the pharmaceutical company's future growth and market capitalization.